Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study

NCT03195660 is registered in ClinicalTrials.gov with ResMed as lead sponsor.

NCT NCT03195660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03195660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Lead sponsor
ResMed
Phase
Not applicable
Overall status
Terminated
Start date
June 26, 2017
Completion date
November 15, 2017
Enrollment
6 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with normal ejection fraction, sleep apnea